Broad T Cell Targeting of Structural Proteins After SARS-CoV-2 Infection: High Throughput Assessment of T Cell Reactivity Using an Automated Interferon Gamma Release Assay.
Saved in:
| Title: | Broad T Cell Targeting of Structural Proteins After SARS-CoV-2 Infection: High Throughput Assessment of T Cell Reactivity Using an Automated Interferon Gamma Release Assay. |
|---|---|
| Authors: | Brand I; Division of Infectious Diseases and Tropical Medicine, University Hospital, Ludwig-Maximilians-Universität (LMU) Munich, Munich, Germany.; Division of Clinical Pharmacology, Department of Medicine IV, University Hospital, LMU Munich, Munich, Germany., Gilberg L; Division of Infectious Diseases and Tropical Medicine, University Hospital, Ludwig-Maximilians-Universität (LMU) Munich, Munich, Germany.; Department of Infectious Diseases, University Hospital, LMU Munich, Munich, Germany., Bruger J; Division of Infectious Diseases and Tropical Medicine, University Hospital, Ludwig-Maximilians-Universität (LMU) Munich, Munich, Germany., Garí M; Institute of Computational Biology, Helmholtz Zentrum München - German Research Center for Environmental Health (HMGU), Neuherberg, Germany., Wieser A; Division of Infectious Diseases and Tropical Medicine, University Hospital, Ludwig-Maximilians-Universität (LMU) Munich, Munich, Germany.; German Center for Infection Research (DZIF), Partner Site Munich, Munich, Germany., Eser TM; Division of Infectious Diseases and Tropical Medicine, University Hospital, Ludwig-Maximilians-Universität (LMU) Munich, Munich, Germany.; German Center for Infection Research (DZIF), Partner Site Munich, Munich, Germany., Frese J; Division of Infectious Diseases and Tropical Medicine, University Hospital, Ludwig-Maximilians-Universität (LMU) Munich, Munich, Germany., Ahmed MIM; Division of Infectious Diseases and Tropical Medicine, University Hospital, Ludwig-Maximilians-Universität (LMU) Munich, Munich, Germany.; German Center for Infection Research (DZIF), Partner Site Munich, Munich, Germany., Rubio-Acero R; Division of Infectious Diseases and Tropical Medicine, University Hospital, Ludwig-Maximilians-Universität (LMU) Munich, Munich, Germany., Guggenbuehl Noller JM; Division of Infectious Diseases and Tropical Medicine, University Hospital, Ludwig-Maximilians-Universität (LMU) Munich, Munich, Germany., Castelletti N; Division of Infectious Diseases and Tropical Medicine, University Hospital, Ludwig-Maximilians-Universität (LMU) Munich, Munich, Germany., Diekmannshemke J; Institute of Computational Biology, Helmholtz Zentrum München - German Research Center for Environmental Health (HMGU), Neuherberg, Germany.; Faculty of Business Administration and Economics, Bielefeld University, Bielefeld, Germany., Thiesbrummel S; Institute of Computational Biology, Helmholtz Zentrum München - German Research Center for Environmental Health (HMGU), Neuherberg, Germany.; Faculty of Business Administration and Economics, Bielefeld University, Bielefeld, Germany., Huynh D; Division of Clinical Pharmacology, Department of Medicine IV, University Hospital, LMU Munich, Munich, Germany., Winter S; Division of Infectious Diseases and Tropical Medicine, University Hospital, Ludwig-Maximilians-Universität (LMU) Munich, Munich, Germany., Kroidl I; Division of Infectious Diseases and Tropical Medicine, University Hospital, Ludwig-Maximilians-Universität (LMU) Munich, Munich, Germany.; German Center for Infection Research (DZIF), Partner Site Munich, Munich, Germany., Fuchs C; Institute of Computational Biology, Helmholtz Zentrum München - German Research Center for Environmental Health (HMGU), Neuherberg, Germany.; Faculty of Business Administration and Economics, Bielefeld University, Bielefeld, Germany.; Center for Mathematics, Technische Universität München, Garching, Germany., Hoelscher M; Division of Infectious Diseases and Tropical Medicine, University Hospital, Ludwig-Maximilians-Universität (LMU) Munich, Munich, Germany.; German Center for Infection Research (DZIF), Partner Site Munich, Munich, Germany.; Center for International Health (CIH), University Hospital, LMU Munich, Munich, Germany., Roider J; Department of Infectious Diseases, University Hospital, LMU Munich, Munich, Germany.; German Center for Infection Research (DZIF), Partner Site Munich, Munich, Germany., Kobold S; Division of Clinical Pharmacology, Department of Medicine IV, University Hospital, LMU Munich, Munich, Germany.; German Center for Translational Cancer Research (DKTK), Partner Site Munich, Munich, Germany.; Unit for Clinical Pharmacology (EKLiP), Helmholtz Zentrum München - German Research Center for Environmental Health (HMGU), Neuherberg, Germany., Pritsch M; Division of Infectious Diseases and Tropical Medicine, University Hospital, Ludwig-Maximilians-Universität (LMU) Munich, Munich, Germany.; German Center for Infection Research (DZIF), Partner Site Munich, Munich, Germany., Geldmacher C; Division of Infectious Diseases and Tropical Medicine, University Hospital, Ludwig-Maximilians-Universität (LMU) Munich, Munich, Germany.; German Center for Infection Research (DZIF), Partner Site Munich, Munich, Germany. |
| Source: | Frontiers in immunology [Front Immunol] 2021 May 20; Vol. 12, pp. 688436. Date of Electronic Publication: 2021 May 20 (Print Publication: 2021). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2021.688436 |
